Cross-sectional HIV and HCV cascades of care across the regions of Ukraine between 2019 and 2020: findings from the CARE cohort.
Olga FursaJoanne ReekieIhor KuzinLarysa HetmanAlina KryshchukOlena StarychenkoNana HrytsaiukInna KhodusAlla NyzhnykViktoriia RakhubaMaryna KovalevskaTetiana MaistatIryna PryhodaMarianna AhieievaOlena VarvarovskaOlena ValdenmaiierJens LundgrenLars Petersnull nullPublished in: Journal of the International AIDS Society (2023)
Over 98% of PLHIV in care in both CARE sites in Ukraine were receiving ART, and the target of 90% virally suppressed was achieved in persons >6 months on ART. Only one of six HIV/HCV study sites tested over 50% anti-HCV-positive PLHIV for HCV-RNA and treated over 25% of eligible persons. While free HCV-RNA testing and DAA treatment are paramount to achieving HCV elimination targets, they remained a challenge in Ukraine in 2019-2020. The extent of the HIV and HCV care disruption during the war will be further assessed in the CARE cohort and compared with the pre-war findings.